BAH vs DY

The Advanced Deterministic Scorecard reveals a mixed financial profile for BAH, with a weak Piotroski F-Score of 4/9 indicating marginal financial health, and no available Altman Z-Score to assess distress risk. Despite strong historical ROE of 75.2% and solid cash flow generation, the company faces significant headwinds with declining revenue and earnings, reflected in negative YoY growth of -8.1% and -52.9%, respectively. Valuation metrics suggest the stock is trading above its Graham Number of $35.57 and growth-based intrinsic value of $49.0, yet at a discount to sector peers on P/E. Analysts have a consensus 'hold' rating with a target price of $102.91, nearly at current levels, while technical trend signals remain bearish.

Dycom Industries presents a stark contrast between fundamental value and market momentum, characterized by a stable Piotroski F-Score of 4/9 and a significant valuation gap. The current price of $410.72 trades at a massive premium to both the Graham Number ($115.57) and the growth-based Intrinsic Value ($66.99). While revenue growth remains explosive at 34.4%, recent earnings growth has contracted sharply (-50.7%), and technical trends are heavily bearish (10/100). The stock is currently a 'growth play' supported by strong analyst consensus, but it lacks a fundamental safety margin.